PetCaseFinder

Peer-reviewed veterinary case report

F3 feline facial pheromone reduces acute stress in cats at vet clinics

By Crump, Ebony·Published in Veterinary Evidence·2023·View original on Crossref

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Effectiveness of F3 feline facial pheromone analogue for acute stress reduction within clinical veterinary practice

Species:
cat
Behaviour & energyCats

Plain-English summary

A cat undergoing a routine veterinary visit showed signs of acute stress, such as excessive vocalization and difficulty being handled. Researchers tested a product called F3 feline facial pheromone (Feliway™) to see if it could help calm stressed cats during exams. The results indicated that the pheromone did help reduce stress indicators, making the cat easier to handle, although it didn't completely eliminate struggling. While Feliway™ can be beneficial, it should be used alongside other stress-reducing techniques for the best results.

People also search for: cat stress at vet · Feliway for calming cats · how to reduce cat anxiety during vet visits

Abstract

PICO Question In cats within a clinical veterinary context, does the application of the F3 feline facial pheromone (Feliway™), when compared to placebo, reduce signs of acute stress? Clinical bottom line Category of research Treatment. Number and type of study designs reviewed Five papers were critically reviewed. There were three prospective, double-blinded, randomised controlled trials, one prospective, single-blinded, randomised controlled trial and one prospective, single-blinded, non-randomised controlled trial. Strength of evidence Moderate. Outcomes reported Four studies found improvement in select indicators of acute stress following F3 feline facial pheromone analogue (FFPA) exposure. One study showed FFPA reduced patient stress during routine physical examination, and improved caregiver impression of patient relaxation and ease of handling. One study revealed FFPA decreased vocalisations but had no effect upon systolic blood pressure during physical examination. One study determined that FFPA calmed but did not reduce struggling during venous catheterisation. One study demonstrated reduced time to sedation and propofol induction dose for routine surgical procedures when a transport protocol incorporating FFPA was applied. Finally, one study found no significant effect of FFPA upon behavioural and physiologic measures of acute stress during physical examination. No studies reported outward negative effects associated with FFPA exposure. Conclusion It can be concluded that FFPA may reduce signs of acute stress within a clinical veterinary context. Additionally, exposure to FFPA is unlikely to cause patient harm. To optimise patient welfare, FFPA is not recommended as a sole agent for stress mitigation and should instead be incorporated holistically with patient friendly handling, clinic design, and pharmacotherapy where indicated. How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources. Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on Crossref: https://doi.org/10.18849/ve.v8i4.669